Bovine dialyzable leukocyte extract modulates cytokines and nitric oxide production in lipopolysaccharide-stimulated human blood cells

Cytotherapy. 2007;9(4):379-85. doi: 10.1080/14653240701320262.

Abstract

Background: In the current study, we determined whether bovine dialyzable leukocyte extract (bDLE) modulates lipopolysaccharide (LPS)-induced nitric oxide and cytokine overproduction.

Methods: Human whole blood cells were treated with LPS (50 ng) + bDLE (1 U).

Results: The bDLE treatment decreased nitric oxide as well as TNF-alpha, IL-6 and IL-10 (P <0.01) cytokine production. In addition, it decreased TNF-alpha, IL-1beta and IL-6 mRNA expression and suppressed IL-10 and IL-12p40 mRNA expression, but did not modulate IL-8 mRNA expression in LPS-stimulated human blood cells.

Discussion: Our results suggest that bDLE may effectively modulate the fatal symptoms of hypotensive shock associated with endotoxin (LPS)-induced nitric oxide and cytokine production, and this may offer therapeutic potential for the treatment of endotoxic shock.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Cells / drug effects*
  • Blood Cells / metabolism*
  • Cattle
  • Cell Survival / drug effects
  • Cytokines / genetics*
  • Cytokines / metabolism*
  • Gene Expression Regulation / drug effects
  • Humans
  • Inflammation Mediators
  • Lipopolysaccharides / pharmacology*
  • Nitric Oxide / biosynthesis*
  • Transfer Factor / pharmacology*

Substances

  • Cytokines
  • Inflammation Mediators
  • Lipopolysaccharides
  • Transfer Factor
  • Nitric Oxide